We hypothesized that PRR contributes to renal inflammation in the 2-kidney, 1-clip (2K1C) renal ischaemia model. Male Sprague-Dawley rats were fed normal sodium diet.
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Summary
We hypothesized that PRR contributes to renal inflammation in the 2-kidney, 1-clip (2K1C) renal ischaemia model. Male Sprague-Dawley rats were fed normal sodium diet.
Blood pressure (BP) was obtained on days 0 and 28 after left renal artery clipping that reduced renal blood flow by 40%. Renal expression of TNF-α, COX-2, NF-κB, IL-1β, MCP-1 and collagen type I were assessed in sham and 2K1C rats with or without left renal administration of scramble or PRR shRNA. At baseline, there were no differences in BP. Compared to sham, MAP significantly increased in clipped animals (sham 102 ± 1.9 vs 2K1C 131.8 ± 3.09 mmHg, P < .05) and was not influenced by scramble or PRR shRNA treatment. Compared to sham and contra lateral (non-clipped) kidney, there was upregulation in mRNA and protein expression of PRR (99% and 45%, P < .01), TNF-α (72% and 50%, P < .05), COX-2 (72% and 39%, P < .05), p-NF-κB (92%, P < .05), MCP-1 (87%, P < .05) and immunostaining of collagen type I in the clipped kidney.
These increases were not influenced by scramble shRNA. Compared to 2K1C and scramble shRNA, PRR shRNA treatment in the clipped kidney significantly reduced the expression of PRR (62% and 57%, P < .01), TNF-α (51% and 50%, P < .05), COX-2 (50% and 56%, P < .05), p-NF-κB by 68% (P < .05), MCP-1 by 73% (P < .05) and collagen type I respectively. Ang II was increased in both kidneys and did not change in response to scramble or PRR shRNA treatments. We conclude that PRR mediates renal inflammation in renal ischaemia independent of blood pressure and Ang II.
K E Y W O R D S
(pro)renin receptor, fibrosis, inflammation
| INTRODUCTION
The kidneys play a pivotal role in physiological functions including blood pressure regulation, and salt and water balance. Renal inflammation and fibrosis are progressive processes that are associated with renal ischaemia, leading to the development of end stage renal disease.
1-3 Previous studies demonstrated a key role for the reninangiotensin system (RAS) in development of hypertension and kidney damage in renovascular hypertension. However, independent of RAS, PRR activation also elicits intracellular signaling via the mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) signaling pathways, leading to cellular proliferation and activation of inflammatory and profibrotic molecules including transforming growth factor β (TGF-β), plasminogen activator inhibitor-1 (PAI-1), IL-1β, nuclear factor-ҡB (NF-ҡB) and COX-2. 5 Cellular activation of the cytokine TGF-β mediates production and deposition of collagen, extracellular matrix, and eventually fibrosis. 6 NFκB plays a pivotal role in this process and reduction of its activity attenuates renal injury through the reduc- 
| RESULTS

| Renal blood flow and blood pressure
| Expression of PRR
Compared to sham (mRNA: 1.00 ± 0.11, WB: 1.00 ± 0.12 AU) and contra lateral NCK (mRNA: 1.07 ± 0.096, WB: 0.84 ± 0.13 AU), total renal mRNA and protein expression of PRR was significantly increased in the CK (mRNA, 1.99 ± 0.15; WB, 1.45 ± 0.13 AU) of 2K1C rats by 99% and 45% respectively (P < .01). There were no significant changes in expression of PRR mRNA and protein in response to left renal administration of scramble shRNA. PRR shRNA treatment significantly reduced total renal expression of PRR mRNA and protein (mRNA, 0.75 ± 0.09; WB, 0.63 ± 0.15 AU) by 62% and 57%, respectively (P < .01; Figure 1A , B).
| Effect of PRR shRNA on TNF-α, COX-2, NF-κB p65 and MCP-1 expression
There were significant increases in CK mRNA (sham 1.0 ± 0.05 vs by 72% and 39%, respectively (P < .05; Figure 1E , F) and increased phosphorylation of NF-κB p65 (sham 1.0 ± 0.04 vs 2K1C
1.92 ± 0.12 AU) by 92% (P < .05; Figure 1G ) and MCP-1 (sham 1.0 ± 0.04 vs 2K1C 1.87 ± 0.08 AU) by 87% (P < .05; Figure 2D ). Figure 1G ). There were no changes in total NF-κB p65 in response to any treatment ( Figure 1H ). MCP-1 expression (2K1C+ Scramble shRNA 2.1 ± 0.21 vs 2K1C+ PRR shRNA 0.5 ± 0.12 AU) was reduced by 76% (P < .05, Figure 2D ) in response to PRR shRNA treatment.
| Renal interstitial fluid (RIF)-interleukin-1β (IL-1β) and angiotensin II (Ang II)
Compared 48.8 ± 2.1 μg/mg respectively; P < .05; Figure 2C ). 
| Urine albumin creatinine ratio (UACR)
| Renal immunostaining for PRR, collagen I
| DISCUSSION
This study demonstrated that PRR expression is upregulated in the ischaemic clipped kidney of the 2K1C Goldblatt rat model and promotes renal injury by upregulating renal inflammation and fibrosis in this model.
Renal ischaemia is associated with increased renin activity and elevated blood pressure. 8 In the 2K1C Goldblatt model, development of inflammation is prominent in the ischaemic kidney and is followed by progressive kidney fibrosis. 6, 9 Previous studies implicated the role of PRR in the pathogenesis of kidney disease. 10, 11 However, the pathologic role of PRR in renal ischaemia is unknown. In the Goldblatt model, renal PRR expression was demonstrated to be increased. 1 Recently, our laboratory demonstrated regulation of PRR expression by the cGMP-PKG signaling pathway and by enhanced binding of CREB-1, NF-κB p65, and c-Jun to the PRR promoter.
12
In addition, we demonstrated PRR involvement in renal production of inflammatory cytokines. 12 In this study, we aimed to evaluate the role of PRR in promoting renal inflammation in renal ischaemia of the 2K1C rat model. We found that PRR expression is upregulated only in the clipped kidney but not in the contralateral non-clipped kidney. This finding is in agreement with the previous observation Activation of Ang II is associated with increased salt and water retention which in turn increases the blood pressure.
17,18
These results again confirm the importance of the RAS in the 2K1C model of Goldblatt hypertension.
Previous studies demonstrated that intrarenal upregulation of inflammatory factors including TNF-α and NF-κB is associated with increased renal Ang II production 19, 20 and contributed to tissue fibrosis and loss of kidney function. 21 In this study, we observed that the intrarenal Ang II level was upregulated in both CK and NCK.
This observation is in agreement with a previous study showing increased Ang II levels in the 2K1C model. In summary, renal ischaemia is associated with increased expression of PRR, NF-κB, the inflammatory cytokine TNF-α, and UACR.
Downregulation of PRR expression in this model reduced inflammation, fibrosis and albuminuria. Therefore, we conclude that PRR plays a significant role in kidney injury in renal ischaemia, independent of Ang II or blood pressure. These findings may help delineate new mechanisms underlying the regulation of renal inflammation and fibrosis in 
| MATERIALS AND METHODS
| Experimental animals preparation, urine collections, and BP measurements
All experimental protocols were approved by the University of 
| Surgical procedures
Rats were anaesthetized with a combination of ketamine (80 mg/kg; i.p.) and xylazine (8 mg/kg; i.p.) and placed on a heating pad throughout the surgery period. Utilizing a sterile technique, a midline laparotomy was performed and the left renal artery was clipped using u-shaped 
(n = 6) (operation was performed on a control group). Rats were maintained for 28 days after surgery.
| Renal blood flow
Changes in renal cortical (RCBF) blood flow were determined by laser flowmeter (Advance Laser Flowmeter ALF 21D, Tokyo, Japan) as described earlier. 
| Western blot analysis
Antibodies to PRR (anti-ATP6IP2/ab40790, Abcam, Cambridge, MA, USA),TNF-α (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), COX-2 (Novus Bilogicals, Littleton, CO, USA), NF-κB p65 (Abcam, Cambridge, MA, USA) and MCP-1 (Cell Signaling, Danvers, MA, USA)
were used in the Western blot (n = 4) as previously described.
12
Protein expression was normalized to β-actin protein.
| Renal PRR and collagen I immunostaining
Left and right kidney tissue blocks were prepared and deparaffinized as described previously.
12 Sections (n = 4) were incubated overnight at 4°C with primary antibody directed against PRR monoclonal antibody (1:100 dilution; anti-ATP6IP2/ab40790; Abcam), collagen I
(1:100 dilution; Abcam). On the following day, sections were incubated for 1 hour with secondary antibody at room temperature. A negative control (IgG) was included by omitting the primary antibody. The immunostaining images were captured by light microscopy using a Qimaging Micropublisher 5.0 RTV camera coupled to a Zeiss Axiophot microscopy (Carl Zeiss, Jena, Germany).
| Urinary albumin creatinine ratio (UACR)
Urinary albumin was determined by using a sensitive rat albumin enzyme immunoassay (EIA) kit (Cayman Chemical, Ann Harbor, MI, USA (n = 4)). Urine creatinine was determined by creatinine assay kit (Cayman). UACR was calculated and presented as albumin in micrograms divided by creatinine in milligrams.
| Statistical analysis
Comparisons among different treatment groups were assessed by ANOVA followed by a Tukey test for post hoc comparisons. Data is expressed as mean ± SE. P < .05 is considered statistically significant.
